Rankings
▼
Calendar
TRDA (Entrada Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena
TRDA
Entrada Therapeutics, Inc.
Mkt Cap
$502M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$25M
Net Income (TTM)
-$144M
EPS (TTM)
-$3.47
Free Cash Flow (TTM)
-$130M
Gross Margin
-54.4%
Op. Margin
-621.1%
Net Margin
-565.5%
FCF Margin
-509.6%
P/S Ratio (TTM)
19.7x
P/E Ratio (TTM)
—
YoY Rev Growth
-87.9%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$25M
$2M
-$6M
Q2 23
$18M
-$8M
-$16M
Q3 23
$44M
$22M
$14M
Q4 23
$42M
$42M
$5M
Q1 24
$59M
$59M
$21M
Q2 24
$95M
$95M
$53M
Q3 24
$20M
$20M
-$22M
Q4 24
$37M
$37M
-$6M
Q1 25
$21M
$21M
-$22M
Q2 25
$2M
$2M
-$47M
Q3 25
$2M
-$37M
-$47M
Q4 25
$1M
$413K
-$42M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
19.9x
—
Q2 23
11.5x
—
Q3 23
5.8x
—
Q4 23
3.9x
—
Q1 24
3.1x
21.4x
Q2 24
2.1x
4.8x
Q3 24
2.3x
9.1x
Q4 24
2.4x
7.6x
Q1 25
2.9x
20.2x
Q2 25
6.3x
—
Q3 25
8.2x
—
Q4 25
19.7x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$203M
$202M
Q2 23
-$35M
-$37M
Q3 23
-$24M
-$26M
Q4 23
-$4M
-$5M
Q1 24
-$26M
-$26M
Q2 24
$40M
$39M
Q3 24
-$24M
-$25M
Q4 24
-$32M
-$32M
Q1 25
-$39M
-$40M
Q2 25
-$29M
-$30M
Q3 25
-$28M
-$28M
Q4 25
-$32M
-$32M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$2M
Q2 23
$2M
Q3 23
$1M
Q4 23
$976K
Q1 24
$838K
Q2 24
$1M
Q3 24
$639K
Q4 24
$635K
Q1 25
$1M
Q2 25
$275K
Q3 25
$171K
Q4 25
$207K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
+40.1%
Q2 23
—
+46.2%
Q3 23
—
+14.6%
Q4 23
—
+44.4%
Q1 24
+134.0%
+22.4%
Q2 24
+421.2%
+19.7%
Q3 24
-55.3%
+38.7%
Q4 24
-10.6%
+17.1%
Q1 25
-65.2%
+11.4%
Q2 25
-97.9%
+18.2%
Q3 25
-91.8%
+18.0%
Q4 25
-96.5%
+0.6%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$3M
10.9%
Q2 23
$0
0.0%
Q3 23
$0
0.0%
Q4 23
$4M
9.2%
Q1 24
$4M
6.3%
Q2 24
$5M
4.9%
Q3 24
$5M
24.8%
Q4 24
$5M
12.6%
Q1 25
$5M
24.7%
Q2 25
$5M
258.9%
Q3 25
$0
0.0%
Q4 25
$4M
335.5%
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q1 23
$23M
$8M
Q2 23
$26M
$8M
Q3 23
$22M
$8M
Q4 23
$28M
$9M
Q1 24
$29M
$9M
Q2 24
$32M
$9M
Q3 24
$31M
$10M
Q4 24
$33M
$10M
Q1 25
$32M
$10M
Q2 25
$38M
$11M
Q3 25
$38M
$10M
Q4 25
$34M
$10M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$228M
$184M
$412M
Q2 23
$80M
$297M
$377M
Q3 23
$52M
$302M
$354M
Q4 23
$68M
$284M
$352M
Q1 24
$68M
$259M
$327M
Q2 24
$185M
$284M
$470M
Q3 24
$78M
$371M
$449M
Q4 24
$101M
$319M
$420M
Q1 25
$68M
$315M
$383M
Q2 25
$72M
$282M
$354M
Q3 25
$93M
$234M
$327M
Q4 25
$90M
$205M
$296M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
32M
+3.3%
Q2 23
33M
+2.4%
Q3 23
35M
+4.9%
Q4 23
33M
-4.0%
Q1 24
35M
+4.3%
Q2 24
36M
+2.1%
Q3 24
41M
+14.4%
Q4 24
43M
+6.0%
Q1 25
41M
-4.6%
Q2 25
41M
+0.6%
Q3 25
41M
+0.3%
Q4 25
41M
-0.2%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 19
—
—
FY 20
—
—
FY 21
$0
114
FY 22
$0
130
FY 23
$811K
159
FY 24
$1M
183
FY 25
$2K
15K
marketcaparena.com